Next expected deadline: TBD

Value & Term

Up to $250,000 per year for up to 3 years


This targeted CRIO Project – Cancer call invites a small group of collaborators (at least three) to submit applications for funding in areas of cancer research across the cancer continuum, from causes and prevention to treatment and care. The focus of this opportunity will be on achieving cancer-related outcomes using a collaborative approach to the production of new knowledge, coupled with the translation of cancer research findings to knowledge- or end-users for impact on the health of Albertans and/or the health system. There is not an expectation that the collaboration will necessarily continue beyond the duration of this non-renewable grant.

How do I apply for the CRIO Project – Cancer?

Important: Please review the CRIO Project – Program Guide (2013/2014), before applying.

What is the review process for CRIO Project – Cancer?

The CRIO Project – Cancer full applications will be evaluated by an expert review committee. The committee will be interdisciplinary and cross-sectoral. The committee will have broad-based representation across the cancer research continuum. It will include investigators with excellent track records of either fostering or conducting interdisciplinary research and/or in leading interdisciplinary research teams from academic and industry sectors, as well as individuals that can provide knowledge transfer and/or end-user perspectives.

While separate research components may be included in the application, each CRIO application will be evaluated as a single, integrated entity. Applicants must demonstrate that the CRIO not only brings added value but is essential to the group’s approach to the complex research question and the health issue being addressed, as well as the group’s ability to generate new knowledge and translate it toward improvements in health or in the health care system.

Applications will be reviewed based on the following assessment criteria:

    • Engagement with knowledge-/end-user collaborators and/or partners: End-user(s) are meaningfully engaged in the proposed research activities providing the support necessary for the deliverables to have the intended impact;
    • Collaborators: The proposed collaborators have the necessary complementary expertise and/or experience to successfully bring the proposed research activities to their planned end-point;
    • Significance and Innovation: The proposed research activities are based on an important and well delineated health question/issue and define a focused set of deliverables;
    • Approach: The collaborative approach described for the proposed research is necessary, integrated, feasible, and aligned to the generation of the specific and defined deliverables;
    • Environment: The environment described for the proposed research will contribute positively to the achievement of the defined objectives.
Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Share on LinkedIn

For more information:
Mike Christen, Officer, Grants Processing
(780) 809-2557